User:David Canner/Sandbox 2
From Proteopedia
(Difference between revisions)
(New page: <div name="wrapper" style="height:100%; overflow:hidden; margin:0; padding:0;"> <div id="JmolPane" class="JmolPanels"> <applet load='2cts' size='100%' frame='true' align='right' caption=...) |
|||
Line 1: | Line 1: | ||
- | + | [[Image: Nexium.jpg|300px|right|thumb| AstraZeneca’s Nexium]] | |
+ | {{#tree:id=siteTree| | ||
+ | <big>The following is a list of major phamerceutical compound targets, organized by disease. </big> | ||
- | + | {{TOC limit|limit=2}} | |
- | + | ==Alzheimer’s Disease== | |
+ | [[Acetylcholinesterase]] <br /> | ||
+ | [[Amyloid Beta]]<br /> | ||
+ | [[Gamma-Secratase]]<br /> | ||
+ | [[Glutamate receptor (GluA2)]]<br /> | ||
- | + | ==Anemia== | |
- | + | [[Erythropoietin]]<br /> | |
- | + | ||
- | + | ==Asthma and other Pulmonary Disease States== | |
- | < | + | [[Beta-2-Andrenergic Receptor]]<br /> |
+ | [[Leukotriene Receptor]]<br /> | ||
- | + | ==Autoimmune Diseases== | |
- | + | [[Tumor Necrosis Factor Receptor]]<br /> | |
- | + | ==Blood Clots & Thrombic Events== | |
+ | [[P2Y12]]<br /> | ||
- | + | **Cancer== | |
+ | ***Growth Factors | ||
+ | ****Epidermal Growth Factor | ||
+ | *****[[Epidermal Growth Factor]] | ||
+ | *****[[Epidermal Growth Factor Receptor]] | ||
+ | ****[[Hepatocyte Growth Factor Receptor]] | ||
+ | ****[[Human Epidermal Growth Factor Receptor 2]] | ||
+ | ****Vascular Growth Factor | ||
+ | *****[[Vascular Endothelial Growth Factor]] | ||
+ | *****[[Vascular Endothelial Growth Factor Receptor]] | ||
+ | ***Kinases | ||
+ | ****[[Cell Division Cycle 7-Related Protein Kinase]] | ||
+ | ****Mitogen-Activated Proteins | ||
+ | *****Mitogen-Activated Protein Kinase | ||
+ | *****Mitogen-Activated Protein Kinase Kinase | ||
+ | *****Mitogen-Activated Protein Kinase Kinase Kinase | ||
+ | ******[[c-Raf]] | ||
+ | ****[[Phosphatidylinositol 3-Kinase]] | ||
+ | ****[[Tyrosine Kinase]] | ||
+ | **[[Heat Shock Protein 90]] | ||
+ | **[[p53]] | ||
+ | **[[Mammalian Target of Rapamycin]] | ||
+ | ==Compromised Immune System== | ||
+ | [[Granulocyte-macrophage colony-stimulating factor]]<br /> | ||
+ | ==Diabetes & Hypoglycemia== | ||
+ | [[Peroxisome Proliferator-Activated Receptors]]<br /> | ||
+ | ==Digestive Diseases== | ||
+ | [[Proton Pump]]<br /> | ||
- | == | + | ==Erectile Dysfunction== |
- | + | [[cGMP-Specific Phosphodiesterase Type 5]]<br /> | |
- | + | ==HIV== | |
+ | [[Reverse Transcriptase]]<br /> | ||
- | + | ==Hypercholesterolemia (Elevated Cholesterol)== | |
+ | [[HMG-CoA Reductase]]<br /> | ||
- | + | ==Hypertension & Congestive Heart Failure== | |
- | </ | + | [[Angiotensin-Converting Enzyme]]<br /> |
+ | [[Calcium Channel]]<br /> | ||
- | </ | + | ==Inflammation & Rheumatoid Arthritis== |
+ | [[Cyclooxygenase]]<br /> | ||
+ | |||
+ | ==Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders== | ||
+ | [[Dopamine Receptor]]<br /> | ||
+ | [[Andrenergic Receptor]]<br /> | ||
+ | [[Histamine Receptor]]<br /> | ||
+ | [[Opioid Receptor]]<br /> | ||
+ | }} |
Revision as of 08:59, 17 September 2010
The following is a list of major phamerceutical compound targets, organized by disease.
Alzheimer’s Disease
Acetylcholinesterase
Amyloid Beta
Gamma-Secratase
Glutamate receptor (GluA2)
Anemia
Asthma and other Pulmonary Disease States
Beta-2-Andrenergic Receptor
Leukotriene Receptor
Autoimmune Diseases
Tumor Necrosis Factor Receptor
Blood Clots & Thrombic Events
Compromised Immune System
Granulocyte-macrophage colony-stimulating factor
Diabetes & Hypoglycemia
Peroxisome Proliferator-Activated Receptors
Digestive Diseases
Erectile Dysfunction
cGMP-Specific Phosphodiesterase Type 5
HIV
Hypercholesterolemia (Elevated Cholesterol)
Hypertension & Congestive Heart Failure
Angiotensin-Converting Enzyme
Calcium Channel
Inflammation & Rheumatoid Arthritis
Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders
Dopamine Receptor
Andrenergic Receptor
Histamine Receptor
Opioid Receptor